Sign in

CIK 0001668243

  • Non-accelerated filer
  • Smaller reporting company

UroGen Pharma Ltd.

Sign in to watch
Ticker
URGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
Operating
Phone
+972 97707601
Business address
9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$182,793
in 3 filings

Net −$182,793. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 8 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-09-04 Schoenberg Mark Chief Medical Officer Exercise or conversion · Restricted Stock Units −1,041 1,042
2020-09-03 Barrett Elizabeth A. Chief Executive Officer Exercise or conversion +8,807 192,693
2020-09-03 Barrett Elizabeth A. Chief Executive Officer Exercise or conversion · Restricted Stock Units −8,807 140,920
2020-09-01 PFREUNDSCHUH PETER P. Chief Financial Officer Exercise or conversion +1,042 8,397
2020-09-01 PFREUNDSCHUH PETER P. Chief Financial Officer Sale −509 $22.82 $12K 7,888
2020-09-01 PFREUNDSCHUH PETER P. Chief Financial Officer Exercise or conversion · Restricted Stock Units −1,042 4,166
2020-08-03 Barrett Elizabeth A. Chief Executive Officer Exercise or conversion +8,807 183,886
2020-08-03 Barrett Elizabeth A. Chief Executive Officer Exercise or conversion · Restricted Stock Units −8,807 149,727
2020-07-27 PFREUNDSCHUH PETER P. Chief Financial Officer Sale −141 $23.51 $3K 7,355
2020-07-27 Schoenberg Mark Chief Medical Officer Sale −70 $23.51 $2K 18,543
2020-07-26 PFREUNDSCHUH PETER P. Chief Financial Officer Exercise or conversion +417 7,496
2020-07-26 PFREUNDSCHUH PETER P. Chief Financial Officer Exercise or conversion · Restricted Stock Units −417 2,500
2020-07-26 Schoenberg Mark Chief Medical Officer Exercise or conversion +209 18,613
2020-07-26 Schoenberg Mark Chief Medical Officer Exercise or conversion · Restricted Stock Units −209 1,250
2020-07-03 Barrett Elizabeth A. Chief Executive Officer Exercise or conversion +8,807 175,079
2020-07-03 Barrett Elizabeth A. Chief Executive Officer Exercise or conversion · Restricted Stock Units −8,807 158,534
2020-06-08 Tomasello Shawn Director Grant or award · Stock Option (right to buy) +10,000 10,000
2020-06-08 Nussbaum Ran Director Grant or award · Stock Option (right to buy) +10,000 10,000
2020-06-08 Holden Stuart Director Grant or award · Stock Option (right to buy) +10,000 10,000
2020-06-08 FALBERG KATHRYN E Director Grant or award · Stock Option (right to buy) +10,000 10,000

Page 20 of 25 · 496 trades